IMRT Cuts Toxicity Without Compromising Efficacy in Gynecolo

IMRT reduces toxicity without compromising efficacy, when compared with CRT, in patients with gynecologic cancers, a phase 3 study suggests.

Related Keywords

, Common Terminology Criteria , Adverse Events , Expanded Prostate Cancer Index Composite , Functional Assessment , Cancer Therapy ,